These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 12958786

  • 1. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
    MMW Fortschr Med; 2003 Jul 24; 145(29-30):61. PubMed ID: 12958786
    [No Abstract] [Full Text] [Related]

  • 2. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschr Med; 2003 May 01; 145(18):54. PubMed ID: 12808824
    [No Abstract] [Full Text] [Related]

  • 3. The cost of COX inhibitors: how selective should we be?
    Marra CA, Esdaile JM, Sun H, Anis AH.
    J Rheumatol; 2000 Dec 01; 27(12):2731-3. PubMed ID: 11128654
    [No Abstract] [Full Text] [Related]

  • 4. Celecoxib: a COX-2 inhibitor.
    Andrews SA, Wallace CK, Davis RL.
    Am J Manag Care; 1999 Apr 01; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract] [Full Text] [Related]

  • 5. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E, Wollheim FA.
    Lakartidningen; 2000 Jun 14; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract] [Full Text] [Related]

  • 6. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr 08; 146(15):66. PubMed ID: 15373027
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
    Ann Intern Med; 2003 May 20; 138(10):I39. PubMed ID: 12755582
    [No Abstract] [Full Text] [Related]

  • 10. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D, Gottlieb S, Godbourt U, Hod H, Kaluski E.
    Harefuah; 2002 Oct 20; 141(10):922-4. PubMed ID: 12420602
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K, Recker DP, Verburg KM.
    Rheumatology (Oxford); 2003 Oct 20; 42(10):1207-15. PubMed ID: 12810937
    [Abstract] [Full Text] [Related]

  • 14. [The coxibs, third generation anti-inflammatories].
    Sternon J.
    Rev Med Brux; 2001 Apr 20; 22(2):100-5. PubMed ID: 11388024
    [Abstract] [Full Text] [Related]

  • 15. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec 20; 12(4):2-4. PubMed ID: 11751079
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL, Eisen GM, Agrawal N, Stenson WF, Kent JD, Verburg KM.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):527-38. PubMed ID: 15339324
    [Abstract] [Full Text] [Related]

  • 19. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
    Einecke D.
    MMW Fortschr Med; 2002 Nov 14; 144(46):68. PubMed ID: 12534087
    [No Abstract] [Full Text] [Related]

  • 20. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F, Harrell K, Fischer R.
    South Med J; 2001 Feb 14; 94(2):256-7. PubMed ID: 11235048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.